Abstract
P220 Long-term safety profile of upadacitinib in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/rheumatology/keac133.219
Journal: Rheumatology | Publication Date: Apr 23, 2022 |
Citations: 1 |
P220 Long-term safety profile of upadacitinib in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis
Join us for a 30 min session where you can share your feedback and ask us any queries you have